Detalhe da pesquisa
1.
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
Cancer
; 129(10): 1537-1546, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882377
2.
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.
Oncologist
; 28(4): 368-372, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200910
3.
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer.
Oncologist
; 27(12): 1004-e926, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124629
4.
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era.
Blood
; 135(22): 1929-1945, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187362
5.
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 1001-1010, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802288
6.
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 290-299, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562230
7.
Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.
Cancer
; 127(3): 391-402, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119140
8.
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Br J Cancer
; 125(1): 28-37, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941878
9.
Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies.
Br J Cancer
; 124(9): 1533-1539, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674736
10.
Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors.
Oncologist
; 26(7): 558-e1098, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491277
11.
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
Oncologist
; 26(7): 588-596, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783054
12.
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
J Transl Med
; 19(1): 13, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407605
13.
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancer.
Invest New Drugs
; 39(5): 1348-1356, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830407
14.
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 39(5): 1357-1365, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909232
15.
Histiocytic Neoplasms, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(11): 1277-1303, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781268
16.
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations.
Oncologist
; 25(1): e160-e169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395751
17.
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Cancer
; 125(3): 463-472, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383888
18.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist
; 24(2): 219-228, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30108156
19.
Accessing Genetic Information with Liquid Biopsies.
Trends Genet
; 31(10): 564-575, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450339
20.
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
Br J Cancer
; 118(6): 763-769, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462132